Oramed initiates Phase 3 Trial of Oral Insulin
Oramed announced that ORMD-0801 is the first oral insulin capsule to achieve the requisite efficacy and safety data enabling them to run the world's first FDA approved phase 3 oral insulin trials in patients with type 2 diabetes who have inadequate glycaemic control
Source:
Biospace Inc.